[HTML][HTML] Prognostic factors influencing clinical outcome of allogeneic hematopoietic stem cell transplantation following imatinib-based therapy in BCR–ABL-positive …
Blood Cancer Journal, 2012 - nature.com
We investigated prognostic factors for the clinical outcome of allogeneic hematopoietic stem
cell transplantation (allo-HSCT) in patients with Philadelphia chromosome-positive acute …
cell transplantation (allo-HSCT) in patients with Philadelphia chromosome-positive acute …
Prognostic factors influencing clinical outcome of allogeneic hematopoietic stem cell transplantation following imatinib-based therapy in BCR–ABL-positive ALL
S Mizuta, K Matsuo, T Maeda, T Yujiri, Y Hatta… - Blood Cancer …, 2012 - cir.nii.ac.jp
抄録 We investigated prognostic factors for the clinical outcome of allogeneic hematopoietic
stem cell transplantation (allo-HSCT) in patients with Philadelphia chromosome-positive …
stem cell transplantation (allo-HSCT) in patients with Philadelphia chromosome-positive …
[PDF][PDF] Prognostic factors influencing clinical outcome of allogeneic hematopoietic stem cell transplantation following imatinib-based therapy in BCR–ABL-positive ALL
S Mizuta, K Matsuo, T Maeda, T Yujiri… - Blood Cancer …, 2012 - scienceopen.com
Approximately 20 to 25% of adult patients with acute lymphoblastic leukemia (ALL) harbor
BCR–ABL fusion gene. The prognosis following conventional chemotherapy of these …
BCR–ABL fusion gene. The prognosis following conventional chemotherapy of these …
Prognostic factors influencing clinical outcome of allogeneic hematopoietic stem cell transplantation following imatinib-based therapy in BCR-ABL-positive ALL.
S Mizuta, K Matsuo, T Maeda, T Yujiri, Y Hatta… - Blood Cancer …, 2012 - europepmc.org
We investigated prognostic factors for the clinical outcome of allogeneic hematopoietic stem
cell transplantation (allo-HSCT) in patients with Philadelphia chromosome-positive acute …
cell transplantation (allo-HSCT) in patients with Philadelphia chromosome-positive acute …
[HTML][HTML] Prognostic factors influencing clinical outcome of allogeneic hematopoietic stem cell transplantation following imatinib-based therapy in BCR–ABL-positive …
S Mizuta, K Matsuo, T Maeda, T Yujiri, Y Hatta… - Blood Cancer …, 2012 - ncbi.nlm.nih.gov
We investigated prognostic factors for the clinical outcome of allogeneic hematopoietic stem
cell transplantation (allo-HSCT) in patients with Philadelphia chromosome-positive acute …
cell transplantation (allo-HSCT) in patients with Philadelphia chromosome-positive acute …
[PDF][PDF] Prognostic factors influencing clinical outcome of allogeneic hematopoietic stem cell transplantation following imatinib-based therapy in BCR–ABL-positive ALL
S Mizuta, K Matsuo, T Maeda, T Yujiri, Y Hatta… - Blood Cancer …, 2012 - core.ac.uk
Approximately 20 to 25% of adult patients with acute lymphoblastic leukemia (ALL) harbor
BCR–ABL fusion gene. The prognosis following conventional chemotherapy of these …
BCR–ABL fusion gene. The prognosis following conventional chemotherapy of these …
[引用][C] Prognostic factors influencing clinical outcome of allogeneic hematopoietic stem cell transplantation following imatinib-based therapy in BCR-ABL-positive ALL
petit.lib.yamaguchi-u.ac.jp
Prognostic factors influencing clinical outcome of allogeneic hematopoietic stem cell
transplantation following imatinib-based therapy in BCR-ABL-positive ALL - Search - 山口県大学 …
transplantation following imatinib-based therapy in BCR-ABL-positive ALL - Search - 山口県大学 …
[PDF][PDF] Prognostic factors influencing clinical outcome of allogeneic hematopoietic stem cell transplantation following imatinib-based therapy in BCR–ABL-positive ALL
S Mizuta, K Matsuo, T Maeda, T Yujiri, Y Hatta… - Blood Cancer …, 2012 - cyberleninka.org
Approximately 20 to 25% of adult patients with acute lymphoblastic leukemia (ALL) harbor
BCR–ABL fusion gene. The prognosis following conventional chemotherapy of these …
BCR–ABL fusion gene. The prognosis following conventional chemotherapy of these …
Prognostic factors influencing clinical outcome of allogeneic hematopoietic stem cell transplantation following imatinib-based therapy in BCR–ABL-positive ALL
S Mizuta, K Matsuo, T Maeda, T Yujiri… - Blood Cancer …, 2012 - nagasaki-u.repo.nii.ac.jp
Approximately 20 to 25% of adult patients with acute lymphoblastic leukemia (ALL) harbor
BCR–ABL fusion gene. The prognosis following conventional chemotherapy of these …
BCR–ABL fusion gene. The prognosis following conventional chemotherapy of these …
Prognostic factors influencing clinical outcome of allogeneic hematopoietic stem cell transplantation following imatinib-based therapy in BCR-ABL-positive ALL
S Mizuta, K Matsuo, T Maeda, T Yujiri… - Blood Cancer …, 2012 - search.proquest.com
We investigated prognostic factors for the clinical outcome of allogeneic hematopoietic stem
cell transplantation (allo-HSCT) in patients with Philadelphia chromosome-positive acute …
cell transplantation (allo-HSCT) in patients with Philadelphia chromosome-positive acute …